[HTML][HTML] Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control …

M Bastepe, LF Fröhlich, GN Hendy… - The Journal of …, 2003 - Am Soc Clin Investig
M Bastepe, LF Fröhlich, GN Hendy, OS Indridason, RG Josse, H Koshiyama, J Körkkö…
The Journal of clinical investigation, 2003Am Soc Clin Investig
Patients with pseudohypoparathyroidism type Ib (PHP-Ib) have hypocalcemia and
hyperphosphatemia due to renal parathyroid hormone (PTH) resistance, but lack physical
features of Albright hereditary osteodystrophy. PHP-Ib is thus distinct from PHP-Ia, which is
caused by mutations in the GNAS exons encoding the G protein α subunit. However, an
imprinted autosomal dominant form of PHP-Ib (AD-PHP-Ib) has been mapped to a region of
chromosome 20q13. 3 containing GNAS. Furthermore, loss of methylation at a differentially …
Patients with pseudohypoparathyroidism type Ib (PHP-Ib) have hypocalcemia and hyperphosphatemia due to renal parathyroid hormone (PTH) resistance, but lack physical features of Albright hereditary osteodystrophy. PHP-Ib is thus distinct from PHP-Ia, which is caused by mutations in the GNAS exons encoding the G protein α subunit. However, an imprinted autosomal dominant form of PHP-Ib (AD-PHP-Ib) has been mapped to a region of chromosome 20q13.3 containing GNAS. Furthermore, loss of methylation at a differentially methylated region (DMR) of this locus, exon A/B, has been observed thus far in all investigated sporadic PHP-Ib cases and the affected members of multiple AD-PHP-Ib kindreds. We now report that affected members and obligate gene carriers of 12 unrelated AD-PHP-Ib kindreds and four apparently sporadic PHP-Ib patients, but not healthy controls, have a heterozygous approximately 3-kb microdeletion located approximately 220 kb centromeric of GNAS exon A/B. The deleted region, which is flanked by two direct repeats, includes three exons of STX16, the gene encoding syntaxin-16, for which no evidence of imprinting could be found. Affected individuals carrying the microdeletion show loss of exon A/B methylation but no epigenetic abnormalities at other GNAS DMRs. We therefore postulate that this microdeletion disrupts a putative cis-acting element required for methylation at exon A/B, and that this genetic defect underlies the renal PTH resistance in AD-PHP-Ib.
The Journal of Clinical Investigation